MedPath

Role of MRI in evaluation of pelvic mass lesions in females

Phase 2
Conditions
Health Condition 1: N00-N99- Diseases of the genitourinary system
Registration Number
CTRI/2024/05/067036
Lead Sponsor
JNMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All female patients undergoing MRI for clinical suspicion of pelvic mass or inconclusive ultrasonographic findings.

Exclusion Criteria

All patients with history of abdominal trauma

Patients with operative history of malignant pelvic mass

Pregnant patients

Patients with metallic implants, pacemaker/cochlear implant

Patients with claustrophobia/any other psychiatric abnormality

Uncooperative patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To detect pelvic masses in females and diagnose them as benign or malignant and estimate the local spread in adjacent pelvic cavity if the mass is malignantTimepoint: 2 years
Secondary Outcome Measures
NameTimeMethod
Observing the shape, size & composition with enhancement pattern of the mass on MRI & <br/ ><br>locating the anatomic origin of the mass for further management.Timepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath